Sevinç Şengül Fatma, Tunca Şahin Gülhan, Özgür Senem, Kafalı Hasan Candaş, Akıncı Okan, Güzeltaş Alper, Ergül Yakup
Departments of Pediatric Cardiology,Sağlık Bilimleri University, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center; İstanbul-Turkey.
Department of Radiology, Sağlık Bilimleri University, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center; İstanbul-Turkey.
Anatol J Cardiol. 2019 Aug;22(2):60-67. doi: 10.14744/AnatolJCardiol.2019.56985.
Arrhythmogenic right ventricular dysplasia (ARVD) is a myocardial genetic disease that occurs primarily in the right ventricle. Patients with ARVD may present with severe ventricular arrhythmias, syncope, and cardiac arrest. The purpose of this study is to evaluate the clinical features and arrhythmic complications of patients with pediatric-onset ARVD.
Patients diagnosed with ARVD between January 2010 and January 2019 were included in this study.
A total of 19 patients with ARVD were evaluated. Of them, 15 patients were male, and their mean age was 12±4 years. The most common symptoms were palpitations (n=6), syncope (n=4), and heart failure symptoms (n=2). Five patients were asymptomatic. Thirteen patients had an epsilon wave; all patients ≥14 years had a T wave inversion in V1-3. Premature ventricular contractions (PVCs) were observed in 15 patients, and ventricular tachycardia (VT) was observed in 9 patients. All patients underwent cardiac magnetic resonance imaging (MRI). Echocardiography and cardiac MRI of two patients were normal at the time of admission; patients were in the concealed phase, and the diagnosis was made by ECG, Holter monitoring, and genetic findings. We administered a beta-blocker in all patients. Two patients underwent an electrophysiological study and ablation because of PVC/VT. An implantable cardiac defibrillator was implanted in 8 patients. The mean follow-up period was 21.5±11 months. Two patients were deceased with incessant VT and heart failure, and one patient was deceased with multiorgan dysfunction after biventricular assist device implantation (n=3).
Diagnosis of pediatric-onset ARVD might be much more difficult in children. Sudden cardiac death might be prevented in the early period by raising the awareness of physicians about the disorder. Prevention of sudden death with implantable cardiac defibrillators is crucial in the management of these patients. It should be kept in mind that children with structurally normal hearts may present with an earlier concealed phase and can be diagnosed with ARVD.
致心律失常性右室心肌病(ARVD)是一种主要发生于右心室的心肌遗传性疾病。ARVD患者可能出现严重室性心律失常、晕厥和心脏骤停。本研究旨在评估儿童期发病的ARVD患者的临床特征及心律失常并发症。
本研究纳入2010年1月至2019年1月期间诊断为ARVD的患者。
共评估了19例ARVD患者。其中,15例为男性,平均年龄为12±4岁。最常见的症状为心悸(n=6)、晕厥(n=4)和心力衰竭症状(n=2)。5例患者无症状。13例患者有epsilon波;所有≥14岁的患者V1-3导联T波倒置。15例患者观察到室性早搏(PVC),9例患者观察到室性心动过速(VT)。所有患者均接受了心脏磁共振成像(MRI)检查。两名患者入院时超声心动图和心脏MRI正常;患者处于隐匿期,诊断通过心电图、动态心电图监测和基因检测结果做出。所有患者均给予β受体阻滞剂治疗。两名患者因PVC/VT接受了电生理检查和消融治疗。8例患者植入了植入式心脏除颤器。平均随访期为21.5±11个月。两名患者死于持续性VT和心力衰竭,一名患者在植入双心室辅助装置后死于多器官功能障碍(n=3)。
儿童期发病的ARVD在儿童中诊断可能困难得多。提高医生对该疾病的认识可在早期预防心源性猝死。植入式心脏除颤器预防猝死在这些患者的管理中至关重要。应牢记,心脏结构正常的儿童可能较早出现隐匿期,且可诊断为ARVD。